Purified THC‑CBD Drug Cuts Agitation in End‑of‑Life Dementia, Trial Shows
Presented July 14, 2026, randomized trial data suggest rapid and lasting symptom relief but the treatment remains unreviewed, unavailable to consumers, and subject to further study and regulation.
